DURAGEN XS DURAL REGENERATION MATRIX

K072207 · Integra Lifesciences Corp. · GXQ · Aug 23, 2007 · Neurology

Device Facts

• Record ID: K072207
• Device Name: DURAGEN XS DURAL REGENERATION MATRIX
• Applicant: Integra Lifesciences Corp.
• Product Code: GXQ · Neurology
• Decision Date: Aug 23, 2007
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 882.5910
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

DuraGen XSTM Dural Regeneration Matrix is indicated as a dura substitute for the repair of dura mater.

Device Story

DuraGen XS is an absorbable, porous collagen matrix used as a sutureless onlay graft for dural repair. It is a soft, white, pliable, nonfriable implant with increased mass and density compared to previous versions. Supplied sterile and nonpyrogenic for single use, it is applied by surgeons during neurosurgical procedures to cover dural defects. The matrix acts as a scaffold for tissue regeneration, facilitating the repair of the dura mater without the need for sutures. It is intended for use in clinical settings.

Clinical Evidence

Bench testing only; no clinical data provided.

Technological Characteristics

Absorbable collagen matrix; porous structure; increased mass and density compared to predicate; supplied sterile and nonpyrogenic; single-use; double peel packaging.

Indications for Use

Indicated for patients requiring repair of the dura mater.

Regulatory Classification

Identification

A dura substitute is a sheet or material that is used to repair the dura mater (the membrane surrounding the brain).

Predicate Devices

• DuraGen Plus Dural Regeneration Matrix (K032693)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the text "K072207" at the top, followed by the word "CONFIDENTIAL" in bold and capital letters. To the right of "CONFIDENTIAL" is the text "page 1/1" in a handwritten font. A horizontal line is at the bottom of the image.

# DuraGen XSTM Dural Regeneration Matrix 510(k) Summary

### Submitter's name and address:

Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, New Jersey 08536 USA

### Contact person and telephone number:

AUG 2 3 2007

Peter Allan Integra LifeSciences Corporation 311 Enterprise Drive Plainsboro, NJ 08536 (609) 936- 2237

Date prepared: August 7, 2007

### Name of device:

DuraGen XS™ Dural Regeneration Matrix Proprietary Name: Dural Graft Matrix Common Name: Classification Name: Dura Substitute

# Substantial Equivalence:

The DuraGen XSTM Dural Regeneration Matrix is substantially equivalent in function and intended use to the currently marketed DuraGen Plus® Dural Regeneration Matrix (K032693).

### Intended Use:

DuraGen XSTM Dural Regeneration Matrix is indicated as a dura substitute for the repair of dura mater.

# Device Description:

DuraGen XS™ Dural Regeneration Matrix is an absorbable implant for repair of dural defects and is to be used as sutureless onlay graft. DuraGen XS™ Dural Regeneration Matrix is an easy to handle, soft, white, pliable, nonfriable, porous collagen matrix with increased mass and density. DuraGen XSTM Dural Regeneration Matrix is supplied sterile, nonpyrogenic, for single use in double peel packages in a variety of sizes.

# Conclusion:

Valid scientific evidence through physical property testing provides reasonable assurance that DuraGen XS™ Dural Regeneration Matrix is safe and effective under the proposed conditions of use, and is, with respect to intended use and technological characteristics, substantially equivalent to the predicate device.

{1}------------------------------------------------

Public Health Service

Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird in flight, composed of three curved lines.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Integra LifeSciences Corporation % Mr. Peter Allan Regulatory Affairs Project Manager 311 Enterprise Drive Plainsboro, New Jersey 08536

AUG 2 3 2007

Re: K072207

Trade/Device Name: DuraGen XS™ Dural Regeneration Matrix Regulation Number: 21 CFR 882.5910 Regulation Name: Dura substitute Regulatory Class: II Product Code: GXP Dated: August 7, 2007 Received: August 8, 2007

Dear Mr. Allan:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{2}------------------------------------------------

Page 2 – Mr. Peter Allan

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours

p.p

DSP Dig
8/23/07

Mark N. Melkerson

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

# Indications for Use

510(k) Number (if known):

Device Name: DuraGen XSTM Dural Regeneration Matrix

Indications For Use:

DuraGen XS™ Dural Regeneration Matrix is indicated as a dura substitute for the repair of dura mater.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

| Concurrence of CDRH, Office of Device Evaluation (ODE) |
|--------------------------------------------------------|
|--------------------------------------------------------|

| Division Sign-Off | · Page 1 of 1 |
|-------------------|---------------|
|-------------------|---------------|

Division of General, Restorative, and Neurological Devices *

| 510(k) Number | 672267 |
|---------------|--------|
|---------------|--------|

B-001